A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilised in a commercial dual-target diagnostic assay
Maria Artesi, Sébastien Bontems, Paul Göbbels, Marc Franckh, Piet Maes, Raphaël Boreux, Cécile Meex, Pierrette Melin, Marie-Pierre Hayette, Vincent Bours, Keith Durkin
doi: https://doi.org/10.1101/2020.04.28.20083337
Maria Artesi
1Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium
Sébastien Bontems
2Department of Clinical Microbiology, University Hospital of Liège, Liège, Belgium
Paul Göbbels
3St-Nikolaus Hospital, Eupen, Belgium
Marc Franckh
3St-Nikolaus Hospital, Eupen, Belgium
Piet Maes
4Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium
Raphaël Boreux
2Department of Clinical Microbiology, University Hospital of Liège, Liège, Belgium
Cécile Meex
2Department of Clinical Microbiology, University Hospital of Liège, Liège, Belgium
Pierrette Melin
2Department of Clinical Microbiology, University Hospital of Liège, Liège, Belgium
Marie-Pierre Hayette
2Department of Clinical Microbiology, University Hospital of Liège, Liège, Belgium
Vincent Bours
1Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium
5Department of Human Genetics, University Hospital of Liège, Liège, Belgium
Keith Durkin
1Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All the viral genomes have been deposited at GISAID
Posted June 23, 2020.
A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilised in a commercial dual-target diagnostic assay
Maria Artesi, Sébastien Bontems, Paul Göbbels, Marc Franckh, Piet Maes, Raphaël Boreux, Cécile Meex, Pierrette Melin, Marie-Pierre Hayette, Vincent Bours, Keith Durkin
medRxiv 2020.04.28.20083337; doi: https://doi.org/10.1101/2020.04.28.20083337
A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilised in a commercial dual-target diagnostic assay
Maria Artesi, Sébastien Bontems, Paul Göbbels, Marc Franckh, Piet Maes, Raphaël Boreux, Cécile Meex, Pierrette Melin, Marie-Pierre Hayette, Vincent Bours, Keith Durkin
medRxiv 2020.04.28.20083337; doi: https://doi.org/10.1101/2020.04.28.20083337
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2657)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12254)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4116)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2666)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (854)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3899)
- Nursing (210)
- Nutrition (579)
- Oncology (2038)
- Ophthalmology (586)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6542)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (185)
- Urology (166)